Featured Research

from universities, journals, and other organizations

Molecular marker could help spot pancreatic cancer early

Date:
May 8, 2010
Source:
University of North Carolina School of Medicine
Summary:
Researchers have identified a molecular marker of pancreatic cancer that may help spot the disease at its earliest stages, when it can be treated more successfully with surgery.

In the lab are Carol A. Otey, Ph.D. on the right, and study first author, Silvia M. Goicoechea, Ph.D.
Credit: Courtney Potter for UNC Medical Center News Office

Researchers at the University of North Carolina at Chapel Hill School of Medicine have identified a molecular marker of pancreatic cancer that may help spot the disease at its earliest stages, when it can be treated more successfully with surgery.

In a finding published April 26, 2010, in the online journal PLoS ONE, the researchers showed that a specific form of a protein called palladin is produced in large amounts in the "tumor nest," the cells that surround a pancreatic tumor.

By measuring the levels of this form of palladin in patient samples, doctors could have an improved way to screen for the deadly cancer, possibly catching it earlier than ever before, said senior study author Carol Otey, Ph.D., associate professor of cell and molecular physiology at UNC.

Otey is a member of the NC Translational and Clinical Sciences Institute (NC TRaCS), part of a collaborative effort of a national network of medical research institutions affiliated with the NIH Clinical and Translational Science Awards (CTSAs).

"The problem with pancreas cancer is it is almost never caught at an early stage," said Otey. "By the time a person develops suspicious symptoms, the disease has typically progressed too far. But if you can diagnose it early, it can be treated very effectively with surgery."

Palladin, a protein which Otey discovered a decade ago, plays an important role in cell motility, adhesion and structure. More recently, Otey and her collaborator Teri Brentnall at the University of Washington showed that palladin was mutated in an inherited form of pancreas cancer and was also produced in large amounts -- "upregulated" -- in a number of sporadic pancreas tumors.

Otey and her colleagues decided to see if this upregulation of palladin could provide a useful diagnostic tool for identifying the disease at earlier stages. They knew that the single palladin gene message can actually be cut and pasted together in a manner that produces at least seven different palladin protein products. Turns out only a couple of these forms of palladin -- called isoforms -- appear in pancreatic tissue.

The researchers found that the longer of these two isoforms was upregulated in the cells surrounding the tumor -- called tumor-associated fibroblasts -- when compared to normal pancreas. Their findings were consistent, regardless of whether they were looking in cultured cell lines, patient samples, or tumors from a mouse model.

Otey thinks that the upregulation of this form of palladin in tumor-associated fibroblasts could help them become contractile and stiff -- more like muscle than connective tissue -- in order to generate channels through neighboring tissue so the cancer can metastasize and spread.

"The interactions between these tumor-associated fibroblasts and tumor cells are really important and are probably what is causing pancreas cancer to be so deadly,invasive and resistant to current therapies," said Otey.

And that is why raising public awareness and enhancing our abilities to diagnose the disease early is so critical, says Hong Jin Kim, associate professor of surgery at UNC, who along with Otey is senior author of the study.

"It appears that the upregulation of palladin in the tumor-associated fibroblasts is an early event in the neoplastic process," said Kim. "We may be able to take advantage of these findings, since pathologic confirmation of pancreatic adenocarcinoma in the preoperative setting is often difficult, requiring an invasive procedure directed by endoscopic ultrasound. If we can enhance the diagnostic efficiency of these studies by staining for palladin, it would be clinically helpful for interventional gastroenterologists and pathologists."

The UNC research was funded in part by the Elsa U. Pardee Foundation and the National Institutes of Health. Study co-authors from UNC include first author Silvia M. Goicoechea, Brian Bednarski, Christianna Stack, David W. Cowan, Keith Volmar, Jen-Jen Yeh, and Leigh Thorne.

Other study co-authors are Sunil Hingorani of the Fred Hutchison Cancer Research Center, Seattle, WA; Edna Cukierman, Fox Chase Cancer Center, Philadelphia, PA; Anil K. Rustgi, University of Pennsylvania; Teresa Brentnall, University of Washington; Rosa F. Hwang, University of Texas M.D. Anderson Cancer Center, Houston, TX; Christopher A.G. McCulloch, University of Toronto, Canada; David J. Bentram, Northwestern Medical Faculty Foundation, Chicago, IL; and Steven Hochwald, University of Florida College of Medicine, Gainesville, FL.


Story Source:

The above story is based on materials provided by University of North Carolina School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Silvia M. Goicoechea, Brian Bednarski, Christianna Stack, David W. Cowan, Keith Volmar, Leigh Thorne, Edna Cukierman, Anil K. Rustgi, Teresa Brentnall, Rosa F. Hwang, Christopher A. G. McCulloch, Jen Jen Yeh, David J. Bentrem, Steven N. Hochwald, Sunil R. Hingorani, Hong Jin Kim, Carol A. Otey. Isoform-Specific Upregulation of Palladin in Human and Murine Pancreas Tumors. PLoS ONE, 2010; DOI: 10.1371/journal.pone.0010347

Cite This Page:

University of North Carolina School of Medicine. "Molecular marker could help spot pancreatic cancer early." ScienceDaily. ScienceDaily, 8 May 2010. <www.sciencedaily.com/releases/2010/04/100426181714.htm>.
University of North Carolina School of Medicine. (2010, May 8). Molecular marker could help spot pancreatic cancer early. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2010/04/100426181714.htm
University of North Carolina School of Medicine. "Molecular marker could help spot pancreatic cancer early." ScienceDaily. www.sciencedaily.com/releases/2010/04/100426181714.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins